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Abstract
Background: Approximately 10–15 % of all clinically recognized pregnancies end in miscarriage, the majority of
them occur during the first trimester, underlying the cause of the loss. Genetic analysis of fetal tissues has the
potential to provide valuable information and is highly recommended in some cases. Around 3–4 years ago, the
gold standard for the analysis was the GTG Kayrotype, is well known that around 50 % of the tissue samples
received failed to grow in culture. Different molecular techniques are used to improve the quality and the
specificity of the study, intending to circumvent the limits of the Karyotype.
Results: Karyolite-BoBs™ (KL-BoB™) assay is a recent bead-based suspension, low density array technology with
consistent results, probed that is an efficient molecular method to detect aneusomies in early pregnancy losses.
Fifty samples from abortions were analyzed in order to probe and give more information about the methodology
and analyze if KL-BoBs™ is a good and cost-efficient strategy. We detected 32 % of chromosomal abnormalities, in
some of the cases more than one aberration was identified, the array CGH validate the observations.
Conclusions: This molecular strategy is a cost-effective sensitive tool in the early pregnancy loss study.
Resumen
Antecedentes: Aproximadamente entre el 10–15 % de los embarazos reconocidos clínicamente terminan en
aborto involuntario. El análisis genético de los tejidos de aborto proporciona información para el seguimiento
médico de algunos casos. El estándar de oro hasta hace pocos años para el análisis de restos embrionarios era el
Cariotipo GTG; sin embargo, alrededor del 50 % de las muestras no logran crecer en cultivo, por lo que
recientemente se ha implementado el uso de las técnicas moleculares. La plataforma Karyolite-BoBs™ es un
microarreglo de baja densidad que analiza con sondas específicas los brazos p, q y centrómeros de los 24
cromosomas los que permite mejorar la calidad y la especificidad del diagnóstico.
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Resultados: Se analizaron 50 muestras de abortos espontáneos procedentes de pacientes con pérdidas
gestacionales recurrentes provenientes de clínicas de reproducción, mediante Karyolite-BoBsTM, con el objetivo de
obtener información del método de análisis y determinar si es una estrategia eficiente con un buen costo-
beneficio. Los resultados se validaron mediante array CGH Constitutional Chip R 4.0 microarray de PerkinElmer
Resultados: En todos los casos se pudo realizar el estudio molecular. Se detectaron 32 % de anomalías
cromosómicas, se observaron alteraciones frecuentes en abortos espontáneos como las trisomías de los
cromosomas 18, 21 y la monosomía del cromosoma X. También se identificaron alteraciones poco frecuentes como
la monosomía de los cromosomas 11 y 19. En un par de casos se observó más de una aberración. Los resultados se
validaron mediante el array CGH y con ambas técnicas se obtuvieron los mismos resultados.
Conclusiones: El análisis molecular mediante Karyolite-BoBsTM es una herramienta sensible y eficaz en costos para
el estudio de tejidos embrionarios de pérdida temprana del embarazo.
Background
Approximately 10–15 % of all clinically recognized preg-
nancies end in miscarriage. The majority of the products
of conception (POC) losses occur during the first trimes-
ter of the gestation, before 20 weeks of gestation. Well-
known studies suggest that around 50 % of the losses are
due to fetal chromosomal abnormalities [1–4].
Genetic analysis of fetal tissues has the potential to
provide valuable information regarding the underlying
cause of miscarriages, allowing a decrement in the cost of
further analysis and genetic counseling of a subsequent re-
currence risk. Information on sporadic abnormality, as
well as on the presence of a structural chromosomal error
associated with a substantial risk for the parents, should
be provided to the patients. Determining the genetic cause
of the reproduction failure is an important issue for
couples who want a healthy pregnancy; the obtained in-
formation has an impact on the family’s plans and fu-
ture management. It has been observed that most
couples feel relieved when they know the cause of the
pregnancy loss [4–6].
Most of the time, these kinds of studies are part of
a protocol for reproductive problems. Until 3 to 4
years ago, the gold standard for genetic analysis was
the tissue culture and chromosomal GTG karyotype.
Consistent evidence in the literature shows that the
tissue culture has many limitations for many reasons,
including the way that POC is obtained, if the sample
needs to be translated to the cytogenetic laboratory,
or if the tissue, per se, has a great potential of con-
tamination. The amount of embryonic material, most
of the time is not enough to obtain reliable results.
The literature indicates that around 50 % of the tissue
samples received failed to grow in culture [7]. In the
remaining cases, the slow cell growth from the time
of the receipt the sample and report is around one
month. It is well known that conventional cytogenetic
techniques depend on skilled technicians; and mater-
nal contamination is not rare, causing errors in the
results like false normal female. For all the reasons men-
tioned above, it is considered that the conventional cyto-
genetic is a not-efficient or cost-efficient, low-throughput
study (Table 1) [5]. The solution to all these problems is
the use of molecular techniques. Different strategies have
been used in order to improve the finding of chromo-
somal abnormalities, trying to circumvent the limits of
the cytogenetic analyses [8–10]. Our laboratory has had
a positive experience with the use of the recent bead-
based suspension, low-density array technology, bacter-
ial chromosome (BAC) on beads (PerkinElmer, Wallac
Oy, Turku, Finland). Two previous papers mention the
utility of this strategy in the POC analysis; our labora-
tory evaluated and probed the feasibility in the abor-
tion tissue analysis using the Karyolite-BACs on Beads
(KL-BoBs™) [11–14], which provides low resolution cover-
age of all chromosomes. Demonstrating this is a good and
cost-efficient strategy that could be used in countries with
low economical resources. In this report, we analyzed 50
consecutive POCs with KL-BoBs™.
Results
KL-BoBs™ was performed in 50 consecutive PCO sam-
ples; all of them were spontaneous, early gestational
losses. The tissue samples were recovered from different
centers and obtaining heterogeneous samples. All the
collected samples were from the first trimester, all were
considered recurrent miscarriages, and all were part of
an assisted reproductive program. In 20 of them, it was
difficult to reach the quality of the sample in the labora-
tory; some of the centers sent large amounts of tissue,
including the gestational sac. However, in all the cases,
the DNA quality was optimums for performing the
assay. The KL-BoBs™ identified 32 % of chromosomal
abnormalities (Table 2). Half of them were as expected,
the most frequent chromosomal abnormalities like
Down and Turner syndromes and one trisomy 13. The
rest of the findings were rare, including, two mono-
somies and one trisomy on the chromosome 19, one
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monosomy of chromosome 14, and one trisomy of
chromosome 11 (Fig. 1). In two cases, a double alter-
ation was identified. In order to corroborate the results,
we validated some of the results with an array CGH
(aCGH) form PerkinElmer Company. The results obtained
with the aCGH were the same as the ones observed with
the KL-BoBs™ (Fig. 2). The results without alterations in
the regions analyzed were 10 cases 46, XY and 24 cases
46, XX. In the 46, XY PCOs the abnormalities were
around 50 % while in the 46, XX were about 19 %.
Discussion
There is no doubt about the tissue culture limitations in
the study of the PCOs. The molecular techniques are
the most reliable strategies for detecting chromosomal
abnormalities in the PCO tissue samples (Table 1). After
a positive experience with the prenatal BOBs™, we de-
cided to analyze a consecutive series of 50 PCOs using
the KL-BoBs™ assay in order to consider this strategy an
affordable and useful strategy for the detection of
chromosomal abnormalities in the abortion samples,
and give more information about the technology and its
limitations in our population. We performed the study
in samples from recurrent early pregnancy losses before
12 weeks of gestation. The literature and our experience
in the laboratory estimated that around 50 % of the sam-
ples fail to grow [1, 7, 10]. Around 90 % of the chromo-
somal findings are due to numerical abnormalities, 6 %
from structural abnormalities, and the remainder from
anomalies such as mosaicism. Chromosomal abnormal-
ity has been found to have a direct correlation with ges-
tational age. Balanced reciprocal translocations are
relatively common, with an incidence around 1:500.
Conventional cytogenetic detects this anomaly, however,
balanced reciprocal translocations do not cause PCO. Is
important to mention that KL-Bobs™ have the potential
to detect the unbalanced progeny of balanced carriers
with a reciprocal translocation [15, 16]. The time to ob-
tain a report takes a month and depends on the cytogen-
etic technician’s skills, and the study resolution is
around 10 to 15 MB. The main point is that conven-
tional cytogenetics is not a cost-efficient and low-
throughput study [5]. Different molecular techniques are
used to improve the quality and the specificity of the
study, intending to circumvent the limits of the GTG
Karyotype. Targeted molecular methods such as multiplex
ligation mediated amplification, quantitative fluorescence
PCR (QF-PCR), and fluorescence in situ hybridization have
been successfully applied to POCs [5, 6]. These methods
are also less sensitive than chromosomal microarrays be-
cause of their low multiplexing capabilities. On the other
hand, performing aCGH is still expensive and is not pos-
sible in all cases. The development of a molecular strategy
based on microarray technology is a good strategy for the
PCO analyses. Three previous reports using a novel strat-
egy with KL-BoBs™ demonstrated that it is a useful strategy
for detecting chromosomal imbalances [13, 17, 18]. Our
experience observed 32 % with abnormalities, which we
considered to be a low percentage, as expected. We
supposed that this is because of the maternal contamin-
ation in the normal 46,XX females. This observation was
confirmed when we analyzed separately the XY results,
obtaining 50 % with abnormalities, as was expected and
reported in the literature. Chromosome abnormalities have
been recognized to be the major factor contributing
















46,XY +21 qcen 1
46,XX del 22qter 1
XY, +19 ptel+19 q cen+22q tel 1
Table 1 KL-BOBs™ and conventional cytogenetic characteristics
KL-BOBs™ GTG Karyotype
Tissue Culture Not necessary Necessary, 50 % fails to grow
Final result 24–48 h 1 month
Interpretation
of the results





















Mosaics Above 15–20 % At leaste25 good quality
metaphases
Cost efficient Cost efficient Not-cost efficient
Advantages and disadvantages of each technique
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to pregnancy loss before 20 weeks of gestation (wg), ac-
counting for 32 to 72 % of all miscarriages [4, 7]. Con-
sidering that maternal contamination is one of the
disadvantages of this technique, this issue could be fixed
with a correct sample reaching; in our case, the large
amount of tissue sent to the lab was the cause of this data.
Nevertheless, the maternal contamination is worse in the
tissue culture because the overgrowth of the maternal cells
over the embryonic or fetal cells increases the false nega-
tive results [19, 20].
After this study, we are teaching the personnel to take
only 0.5 cm of the embryonic or embryonic sac tissue
sample, no more, and put it in a 2 mL eppendorf collec-
tion tube. Paxton et al., after studying 3794 consecutive
clinical cases, discussed that, with a perfect performance
of the assay, as many as 90 % of all PCOs could be cor-
rectly classified by this assay when compared with the
karyotype [20]. This could be a distinctive advantage in
terms of more rapid results, elimination of the tissue
culture, and the fact that it is a low-cost assay compared
with the microarrays. One of the major limitations of
the KL-BoBs ™ technique is that it cannot detect triploid,
tetraploid, or structural abnormalities, which, together,
comprise about 10 % of the total of PCOs etiology. One
report in the literature demonstrated the ability of this
technique to detect male prenatal triploidy [11]. In our
lab, at least 200 prenatal tests have been done and this
phenomenon has never been observed. The assay could
detect mosaics when they have more than 20–30 % of
the cells; so far, this is a disadvantage if there is a low
percentage mosaic. Previous reports showed that the
findings observed by the KL-BoBs™ were corroborated
by aCGH, in which the array was done in 99/100 sam-
ples with Single Nucleotide Polymorphism (SNP) 6.0
microarray; results of the KL-BoBs™ assay were 100 %
concordant with the microarray for all the aneusomies
[21]. Nevertheless, the microarray has a higher reso-
lution while KL-BoBs™ has a very high sensitivity for
aneusomies detection. The aCHG that we performed in
some of our samples corroborated the diagnosis per-
formed with the KL-BoBs™. In our series, we found more
than one aneusomie, which is not an unusual finding be-
cause the technology is capable to detect it. In a previ-
ous series, the authors found that around 74 % of the
PCOs have more than one aneusomie. These observa-
tions are quite difficult to observe with conventional
Fig. 1 Cases whit trisomy 18. a Karyolite BoBs female with gain in chromosome 18. b Trisomy of chromosome 18 was confirmed by array
comparative genomic hybridization whit a Constitutional ChipR 4.01 microarray, PerkinElmer
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Fig. 2 Examples of KL-BoBs™ results, samples with normal and abnormal results: a Normal female (46, XX); b Normal male (46, XY); c Female whit
gain of chromosome 18 (47,XX +18); d Female whit gain of chromosome 21 (47,XX +21); e Female whit loss of chromosome 19 (45,XX −19); f
Turner with a loss of chromosome 19 (44, X0 −19); g Turner (45, X0); h Female whit a loss of 22qtel probe (46,XX – 22qtel)
Fig. 3 KaryoLite™ BoBs™ assay design. Each bead is a composite of multiple neighboring bacterial artificial chromosomes according to the
Human Genome Build GRCh37.2/hg19 assembly. For each chromosome, except the acrocentric ones, two beads per arm were used, providing
dosage information on telomeric and pericentromeric regions. Figure from PerkinElmer educational material
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karyotypes, while KL-BoBs™ and the microarray are good
strategies for detecting them.
In conclusion, the use of KL-BoBs™ is a sensitive mo-
lecular tool to analyze the 46 chromosomes in PCOs,
and detect aneusomies with a cost-effective study. SNPs
and CGH array analysis are expensive, while this mo-
lecular analysis performs a successful low-density array
for the 46 chromosomes.
Methods
Fifty POCs were included in the study and all samples
were single pregnancies. Samples were collected in a
saline solution and transported at room temperature.
Purified DNA was extracted directly from residual clean-
ing, using QIAamp DNA Mini Kit extraction reagents
for tissues (Qiagen, USA). The quality and the amount
of the DNA were analyzed with a nanodrop instrument.
KaryoLite-BoBs™
The microarray KL-BoBs™ was performed with 240 ng of
genomic DNA from abortion tissues. The assay provides
dosage information about the proximal and terminal re-
gions of each chromosome arm by using beads: 91 beads
are a composite of three neighboring BACs in equal
Fig. 4 Representative KaryoLite-BoBs™, result from the normal female 46, XX. The Graphically plot shows the hybridization intensity of each probe
set, in the 24chomosomes, in relation to the female (red) and male (blue) reference standards
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amounts, according to the Human Genome Build
(GRCh37.2/hg19) assembly, which detects arm-specific
aneuploidies in all 24 chromosomes in a single assay.
The microarray includes beads composed of three BACs
and covers centromere, p and q arms of all chromo-
somes (1–22, X and Y) (Fig. 3). The product covers q
arms in acrocentric chromosomes. BACs-on-Beads tech-
nology consists of BAC DNA immobilized into polystyr-
ene microspheres distinguishable by the Luminex®
instrument system. The assay utilizes probes immobi-
lized on polystyrene microspheres (beads) and impreg-
nated with a specific ratio of red to infrared dyes to
allow bead identification (Fig. 3).
The procedure is summarized in four steps:
1. Labeling of genomic DNA. Purified whole genome
DNA from the sample, male and female controls
(Promega, Madison, WI) 240 ng was linearly
amplified with a biotin-labeled dNTPs mix at 37 °C
for 60 min.
2. Purification of labeled DNA. Labeled DNA was
purified with the PureLink™ PCR Purification Kit
(Invitrogen/Life Technologies, CA) to remove
un-hybridized biotin-labeled dNTPs. DNA was
quantified with a nanodrop and diluted to 150 to
200 ng/μL.
3. DNA hybridization. Biotin-labeled samples and
controls were hybridized to the Karyolite-BoBs™ bead
set in a TriNest™ shaking incubator (PerkinElmer,
Turku, Finland) at 52 °C to 1200 rpm for 16 h.
4. DNA washing and reporter binding. The reaction
was stopped with a wash buffer and shaken at
50 °C for 20 more minutes. The biotin-labeled
DNA hybridized was revealed with streptavidin
phycoerythrin for 30 min at 37 °C.
Samples were washed and run on a Luminex100–200™.
The Luminex technology employs a red–infrared laser to
identify the region of each probe and measures the relative
amount of biotin-labeled DNA hybridized to each bead
with a green laser. The aneusomy analysis was performed
using a software program, BoBsoft™ v1.1, PerkinElmer,
Waltham, MA. In BoBsoft™.
Aneusomy detection with the KL-BoBs™ assay was per-
formed by comparing the test sample on four reference
DNA samples (two female and two male; Promega,
Madison, WI). The Luminex .csv data file was imported
and the data was analyzed using a software program (BoB-
soft™ v1.1, PerkinElmer, Waltham, MA). In BoBsoft™,
chromosome enumeration is presented numerically as a
sample to reference ratios for each probe set (i.e. bead),
and graphically as a plot, showing the hybridization inten-
sity of each probe set in relation to the female (red) and
male (blue) reference standards (Fig. 4).
Constitutional Chip R 4.0 microarray
The constitutional Chip 4.0 is comprised of BAC (Bac-
terial Artificial Chromosome) clones containing large
segments (~100–300 kb) of human DNA. With ap-
proximately 5000 clones, the constitutional Chip 4.0
covers the whole human genome with an average
resolution of ˂650 kb, the array is high resolution
tool for detecting gains or losses of DNA in chromo-
somes. Two 2 μg of purified DNA were required for
analysis. Labelling and hybridization of test and reference
DNA were performed according to the manufacturer’s pro-
tocols. Test and reference DNA were labelled by Cy3 and
Cy5 on two independent labeling reactions, with reciprocal
labelling reactions, and were hybridized for 16 h. Arrays
were washed four times according to the protocol.
Two color scans were performed by the PerkinElmer®
Inc.’s ScanArray® Microarray Scanner. Data extraction,
analysis, and visualization were done by the Oneclick
CGH software, PerkinElmer Edition. Data from the
hybridization experiment was represented as a ratio
of the two signals (Cyanine 3/Cyanine 5) and normal-
ized to correct for non-biological effects in the data.
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